KORU Medical Systems Inc has a consensus price target of $3.75, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from B. Riley Securities, Canaccord Genuity, and Lake Street on March 14, 2024, December 7, 2023, and September 7, 2023. With an average price target of $3.67 between B. Riley Securities, Canaccord Genuity, and Lake Street, there's an implied 67.43% upside for KORU Medical Systems Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/14/2024 | KRMD | Buy Now | KORU Medical Systems | $2.19 | 82.65% | B. Riley Securities | William Woods | $4 → $4 | Reiterates | Buy → Buy | Get Alert |
12/07/2023 | KRMD | Buy Now | KORU Medical Systems | $2.19 | 36.99% | Canaccord Genuity | Caitlin Cronin | → $3 | Reiterates | Buy → Buy | Get Alert |
09/07/2023 | KRMD | Buy Now | KORU Medical Systems | $2.19 | 82.65% | Lake Street | Frank Takkinen | → $4 | Initiates | → Buy | Get Alert |
09/07/2023 | KRMD | Buy Now | KORU Medical Systems | $2.19 | 105.48% | B. Riley Securities | Neil Chatterji | → $4.5 | Initiates | → Buy | Get Alert |
08/03/2023 | KRMD | Buy Now | KORU Medical Systems | $2.19 | 36.99% | Piper Sandler | Jason Bednar | $4.5 → $3 | Maintains | Overweight | Get Alert |
01/06/2023 | KRMD | Buy Now | KORU Medical Systems | $2.19 | 105.48% | Piper Sandler | Jason Bednar | $3.5 → $4.5 | Maintains | Overweight | Get Alert |
11/10/2022 | KRMD | Buy Now | KORU Medical Systems | $2.19 | 82.65% | Canaccord Genuity | Kyle Rose | $3 → $4 | Upgrade | Hold → Buy | Get Alert |
11/10/2022 | KRMD | Buy Now | KORU Medical Systems | $2.19 | 59.82% | Piper Sandler | Jason Bednar | $3 → $3.5 | Upgrade | Neutral → Overweight | Get Alert |
The latest price target for KORU Medical Systems (NASDAQ: KRMD) was reported by B. Riley Securities on March 14, 2024. The analyst firm set a price target for $4.00 expecting KRMD to rise to within 12 months (a possible 82.65% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for KORU Medical Systems (NASDAQ: KRMD) was provided by B. Riley Securities, and KORU Medical Systems reiterated their buy rating.
The last upgrade for KORU Medical Systems Inc happened on November 10, 2022 when Canaccord Genuity raised their price target to $4. Canaccord Genuity previously had a hold for KORU Medical Systems Inc.
There is no last downgrade for KORU Medical Systems.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of KORU Medical Systems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for KORU Medical Systems was filed on March 14, 2024 so you should expect the next rating to be made available sometime around March 14, 2025.
While ratings are subjective and will change, the latest KORU Medical Systems (KRMD) rating was a reiterated with a price target of $4.00 to $4.00. The current price KORU Medical Systems (KRMD) is trading at is $2.19, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.